Abstract

Background The membrane proximal external region (MPER) of HIV-1 is an important target of broadly cross-reactive mAbs. CAPRISA participant, CAP206, developed antiMPER antibodies early that became cross-neutralizing at 18 months post-infection. This coincided with neutralization of the C4 HIV-2/HIV-1 chimera containing the W670 residue, suggesting changes in an antibody paratope may have resulted in the acquisition of breadth. A neutralizing mAb (CAP206-CH12) was isolated, providing an opportunity to determine which somatic hypermutations contribute to breadth. Methods The putative CAP206-CH12 reverted unmutated ancestor (RUA) was inferred using SoDA (http://www.dulci.org). Batch transient transfections were used to generate recombinant antibodies. Neutralization breadth and potency was tested against autologous, Tier 2, and HIV-2/HIV-1 MPER chimeric viruses using the TZM-bl assay. Binding to MPER peptides was assessed by ELISA and surface plasmon resonance (SPR). Results CAP206-CH12_RUA bound the MPER.03 peptide with a Kd of 120nM, 15-fold weaker than CAP206-CH12 binding, but had no neutralizing activity. Since CAP206CH12 and its RUA differed by 19 residues in the heavy chain and 9 in the light chain, we designed an intermediate precursor (IP) where changes near the CDRs in CAP206-CH12 were reverted back to the germline sequence (11 in the heavy and 5 in the light chain). This CAP206-CH12_IP did not neutralize the C4 chimera suggesting that changes responsible for the affinitymatured CAP206-CH12 neutralizing capacity were among these 16 residues. Chimeric pairs of the light chain IP with the heavy chain of CAP206-CH12 or CAP206-CH12_RUA showed binding to MPER with differences in binding kinetics. Conclusion The reduced binding and neutralizing activity of CAP206CH12_RUA and CAP206-CH12_IP compared to CAP206CH12 suggests a correlation between affinity maturation, neutralization breadth and potency. Ongoing work will assess the affinity maturation of CAP206-CH12 by determining moieties in the antibody paratope associated with effective epitope recognition and the effects of somatic mutations on the evolution of neutralization.

Highlights

  • The membrane proximal external region (MPER) of HIV-1 is an important target of broadly cross-reactive mAbs

  • CAPRISA participant, CAP206, developed antiMPER antibodies early that became cross-neutralizing at 18 months post-infection

  • Since CAP206CH12 and its reverted unmutated ancestor (RUA) differed by 19 residues in the heavy chain and 9 in the light chain, we designed an intermediate precursor (IP) where changes near the CDRs in CAP206-CH12 were reverted back to the germline sequence (11 in the heavy and 5 in the light chain)

Read more

Summary

Background

The membrane proximal external region (MPER) of HIV-1 is an important target of broadly cross-reactive mAbs. CAPRISA participant, CAP206, developed antiMPER antibodies early that became cross-neutralizing at 18 months post-infection. CAPRISA participant, CAP206, developed antiMPER antibodies early that became cross-neutralizing at 18 months post-infection This coincided with neutralization of the C4 HIV-2/HIV-1 chimera containing the W670 residue, suggesting changes in an antibody paratope may have resulted in the acquisition of breadth. A neutralizing mAb (CAP206-CH12) was isolated, providing an opportunity to determine which somatic hypermutations contribute to breadth

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call